EUVIMEDEUVIMED entdecken
Crossref

Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression

Laura Wormser iD, Sabrina Kojic, Valerie Fritz iD, Matthias Benkert, Miriam Düll iD, Maximilian Waldner, Jürgen Siebler, Jonel Trebicka iD, Claus Hellerbrand iD, Markus F Neurath, Anja K Bosserhoff iD, Peter Dietrich iD

The Journal of Pathology · 2026-12 · 270 (4) · 455-467

DOI: 10.1002/path.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 19.08.2026. Verfasst von Laura Wormser und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Pancreatic Polypeptide, Protein Precursors. Die Arbeit nennt 87 Literaturangaben. Gefördert von: Interdisciplinary Center for Clinical Research Erlangen, Else Kröner-Fresenius-Stiftung, Bundesministerium für Forschung, Technologie und Raumfahrt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic polypeptide (PP) and neuropeptide Y4 receptor (Y4R) are part of a conserved system that is involved in appetite regulation, gastrointestinal functions, and energy homeostasis. Experimental evidence suggests that PP–Y4R signaling might play a role in various extrahepatic cancer types, but the exact mechanisms remain unclear. Moreover, the potential role of PP–Y4R crosstalk in hepatocellular carcinoma (HCC) was unknown and has been addressed in this study. We found that the ligand (PP) and the receptor (Y4R) were markedly overexpressed in HCC cells and in patient‐derived tissues, which was correlated with a poor prognosis. Mechanistically, we found that PP promoted migration of HCC cells mediated via activation of extracellular signal‐regulated kinase (ERK) signaling. Knockdown of Y4R or pharmacological inhibition of Y4R decreased migration, clonogenicity, and proliferation of HCC cells and induced a G1‐cell cycle arrest and cellular senescence. Conversely, activation of the PP–Y4R axis was sufficient to overcome both spontaneous and sorafenib‐induced senescence, which was mediated by ERK signaling. Our study provides novel insights into the pro‐tumorigenic roles of PP and Y4R in HCC, indicating that PP–Y4R crosstalk might represent a potential novel therapeutic target. © 2026 The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularPancreatic PolypeptideProtein PrecursorsReceptors, Neuropeptide YCell Line, TumorHumansDisease ProgressionSignal TransductionCell ProliferationCell MovementCellular Senescence

Stichwörter der Autor:innen

HCCNPY4RPPY4Rhepatocellular carcinomaliver cancerneuropeptide Y4 receptorpancreatic polypeptideresistancesorafenib

Substanzen

PPY protein, humanPancreatic PolypeptideProtein Precursorsneuropeptide Y4 receptorReceptors, Neuropeptide Y

Autor:innen und Institutionen

  • Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
  • Comprehensive Cancer Center Erlangen-European Metropolitan Region Nuremberg, Erlangen, Germany.
  • Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.
  • European Reference Network for Rare Hepatological Diseases, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

ORCID-Profile: Laura Wormser, Valerie Fritz, Miriam Düll, Jonel Trebicka, Claus Hellerbrand, Anja K Bosserhoff, Peter Dietrich

Förderung

  • Interdisciplinary Center for Clinical Research Erlangen
  • Else Kröner-Fresenius-Stiftung
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • Wilhelm Sander-Stiftung
  • Deutsche Krebshilfe
  • Deutsche Forschungsgemeinschaft
  • Bayerisches Zentrum für Krebsforschung
  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Wormser, L., Kojic, S., Fritz, V., Benkert, M., Düll, M., Waldner, M., Siebler, J., Trebicka, J., Hellerbrand, C., Neurath, M. F., Bosserhoff, A. K., & Dietrich, P. (2026). Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression. The Journal of Pathology, 270(4), 455-467. https://doi.org/10.1002/path.70115

Vancouver

Wormser L, Kojic S, Fritz V, Benkert M, Düll M, Waldner M, et al. Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression. The Journal of Pathology. 2026;270(4):455-467. doi:10.1002/path.70115

BibTeX
@article{Wormser2026,
  author = {Wormser, Laura and Kojic, Sabrina and Fritz, Valerie and Benkert, Matthias and Düll, Miriam and Waldner, Maximilian and Siebler, Jürgen and Trebicka, Jonel and Hellerbrand, Claus and Neurath, Markus F and Bosserhoff, Anja K and Dietrich, Peter},
  title = {Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression},
  journal = {The Journal of Pathology},
  year = {2026},
  volume = {270},
  number = {4},
  pages = {455--467},
  doi = {10.1002/path.70115}
}
Kostenlos starten →